CDKN2A and chronic kidney disease: The expression of SA‐β‐gal and cyclin‐dependent kinase inhibitor 2A (CDKN2A) gene encoding p16Ink4a was higher in the ADMSCs from patients with CKD than in those from control subjects, confirming the CKD‐associated cellular senescence in human MSCs (Figure 5a,b).